The Valley Desk

ArticleJTO clinical and research reportsPublished

Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Penn Presbyterian Medical Center, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
JTO clinical and research reports
Published
Subject terms
NSCLC; LAT; Oligometastatic; Pembrolizumab
PubMed ID
38799131
PubMed Central ID
PMC11126925
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal